155 related articles for article (PubMed ID: 34734510)
21. Neurologic Effects of Gadolinium Retention in the Brain after Gadolinium-based Contrast Agent Administration.
Ayers-Ringler J; McDonald JS; Connors MA; Fisher CR; Han S; Jakaitis DR; Scherer B; Tutor G; Wininger KM; Dai D; Choi DS; Salisbury JL; Jannetto PJ; Bornhorst JA; Kadirvel R; Kallmes DF; McDonald RJ
Radiology; 2022 Mar; 302(3):676-683. PubMed ID: 34931861
[TBL] [Abstract][Full Text] [Related]
22. Gadolinium-Based Contrast Agents in Kidney Disease: Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists.
Schieda N; Blaichman JI; Costa AF; Glikstein R; Hurrell C; James M; Jabehdar Maralani P; Shabana W; Tang A; Tsampalieros A; van der Pol C; Hiremath S
Can Assoc Radiol J; 2018 May; 69(2):136-150. PubMed ID: 29706252
[TBL] [Abstract][Full Text] [Related]
23. Effect of at Least 10 Serial Gadobutrol Administrations on Brain Signal Intensity Ratios on T1-Weighted MRI in Children: A Matched Case-Control Study.
Ozturk K; Nascene D
AJR Am J Roentgenol; 2021 Sep; 217(3):753-760. PubMed ID: 33112200
[No Abstract] [Full Text] [Related]
24. Gadolinium deposition in the brain is related to various contrast agents: a matched case-control study.
Bi Q; Li H; Du J; Li H; Li Q; Wang J; Huang Y; Gong X
Clin Radiol; 2022 Apr; 77(4):299-306. PubMed ID: 35094817
[TBL] [Abstract][Full Text] [Related]
25. Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents.
Kiviniemi A; Gardberg M; Ek P; Frantzén J; Bobacka J; Minn H
Neuroradiology; 2019 May; 61(5):535-544. PubMed ID: 30710184
[TBL] [Abstract][Full Text] [Related]
26. Patterns of use, effectiveness and safety of gadolinium contrast agents: a European prospective cross-sectional multicentre observational study.
Jakobsen JÅ; Quattrocchi CC; Müller FHH; Outteryck O; Alcázar A; Reith W; Fraga P; Panebianco V; Sampedro A; Pietura R
BMC Med Imaging; 2021 Apr; 21(1):74. PubMed ID: 33879075
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents.
Strzeminska I; Factor C; Robert P; Grindel AL; Comby PO; Szpunar J; Corot C; Lobinski R
Invest Radiol; 2020 Mar; 55(3):138-143. PubMed ID: 31917763
[TBL] [Abstract][Full Text] [Related]
28. Assessment of immediate and non-immediate hypersensitivity contrast reactions by skin tests and provocation tests: A review.
Bansie RD; Karim AF; van Maaren MS; Hermans MA; van Daele P; Gerth van Wijk R; Rombach SM
Int J Immunopathol Pharmacol; 2021; 35():20587384211015061. PubMed ID: 34053316
[TBL] [Abstract][Full Text] [Related]
29. Gadolinium-based Contrast Agents for Cardiac MRI: Use of Linear and Macrocyclic Agents with Associated Safety Profile from 154 779 European Patients.
Uhlig J; Al-Bourini O; Salgado R; Francone M; Vliegenthart R; Bremerich J; Lotz J; Gutberlet M
Radiol Cardiothorac Imaging; 2020 Oct; 2(5):e200102. PubMed ID: 33778622
[TBL] [Abstract][Full Text] [Related]
30. Gadolinium Deposition in the Brain: A Systematic Review of Existing Guidelines and Policy Statement Issued by the Canadian Association of Radiologists.
Costa AF; van der Pol CB; Maralani PJ; McInnes MDF; Shewchuk JR; Verma R; Hurrell C; Schieda N
Can Assoc Radiol J; 2018 Nov; 69(4):373-382. PubMed ID: 30249408
[TBL] [Abstract][Full Text] [Related]
31. Pathophysiology of Immediate Reactions to Injectable Gadolinium-based Contrast Agents.
Carr TF
Top Magn Reson Imaging; 2016 Dec; 25(6):265-268. PubMed ID: 27748716
[TBL] [Abstract][Full Text] [Related]
32. 75% negative skin test results in patients with suspected hypersensitivity to beta-lactam antibiotics: Influencing factors and interpretation of test results.
Joerg L; Hasler S; Gschwend A; Meincke C; Nordmann TM; Glatz M; Heilig M; Schnyder B; Helbling A; Schmid-Grendelmeier P
World Allergy Organ J; 2021 Nov; 14(11):100602. PubMed ID: 34820050
[TBL] [Abstract][Full Text] [Related]
33. Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study.
Tibussek D; Rademacher C; Caspers J; Turowski B; Schaper J; Antoch G; Klee D
Radiology; 2017 Oct; 285(1):223-230. PubMed ID: 28640695
[TBL] [Abstract][Full Text] [Related]
34. Species-dependent interaction of Gd-based contrast agents with humic substances.
Sommer K; Sperling M; Karst U
Chemosphere; 2022 Aug; 300():134528. PubMed ID: 35427668
[TBL] [Abstract][Full Text] [Related]
35. Immediate reactions to iodinated contrast media.
Morales-Cabeza C; Roa-Medellín D; Torrado I; De Barrio M; Fernández-Álvarez C; Montes-Aceñero JF; De La Riva I; Prieto-García A
Ann Allergy Asthma Immunol; 2017 Dec; 119(6):553-557. PubMed ID: 29017901
[TBL] [Abstract][Full Text] [Related]
36. Switching from linear to macrocyclic gadolinium-based contrast agents halts the relative T
Rowe SK; Rodriguez D; Cohen E; Grundy R; Morgan PS; Jaspan T; Dineen RA
J Magn Reson Imaging; 2020 Jan; 51(1):288-295. PubMed ID: 31165554
[TBL] [Abstract][Full Text] [Related]
37. Linear gadolinium-based contrast agent (gadodiamide and gadopentetate dimeglumine)-induced high signal intensity on unenhanced T
Ichikawa S; Omiya Y; Onishi H; Motosugi U
J Magn Reson Imaging; 2019 Apr; 49(4):1046-1052. PubMed ID: 30307671
[TBL] [Abstract][Full Text] [Related]
38. Speciation Analysis of Gadolinium in the Water-Insoluble Rat Brain Fraction After Administration of Gadolinium-Based Contrast Agents.
Strzeminska I; Factor C; Robert P; Szpunar J; Corot C; Lobinski R
Invest Radiol; 2021 Sep; 56(9):535-544. PubMed ID: 33813574
[TBL] [Abstract][Full Text] [Related]
39. Empiric Switching of Gadolinium-Based Contrast Agents in Patients With History of Previous Immediate Hypersensitivity Reaction to GBCA: A Prospective Single-Center, Single-Arm Efficacy Trial.
Walker D; McGrath TA; Glikstein R; Chakraborty S; Blanchette C; Schieda N
Invest Radiol; 2021 Jun; 56(6):369-373. PubMed ID: 33337738
[TBL] [Abstract][Full Text] [Related]
40. Clinical usefulness of patch and challenge tests in the diagnosis of cell-mediated allergy to betalactams.
Patriarca G; D'Ambrosio C; Schiavino D; Larocca LM; Nucera E; Milani A
Ann Allergy Asthma Immunol; 1999 Sep; 83(3):257-66. PubMed ID: 10507273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
